Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
37.10
+0.40 (1.09%)
Oct 24, 2025, 5:00 PM CET
1.09%
Market Cap680.99M
Revenue (ttm)373.90M
Net Income (ttm)465.00K
Shares Out18.36M
EPS (ttm)0.03
PE Ratio1,464.49
Forward PE224.85
Dividendn/a
Ex-Dividend Daten/a
Volume22,176
Average Volume19,603
Open36.10
Previous Close36.70
Day's Range36.10 - 37.30
52-Week Range26.50 - 58.10
Beta0.19
RSI54.24
Earnings DateNov 9, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.